Amgen - In the News - Enbrel� in the News

print
mail

Overview

Fact Sheets

Featured Content

Press Releases

Social Media

Media Contacts

Virtual Press Kits

In the News

Enbrel® (etanercept) in the News


Apr.24, 2009	Amgen and Wyeth announce ENBREL Support� Program
Mar.18, 2009	Amgen Statement on Alzheimer's Case Study
Sept. 4, 2008	Amgen and Wyeth Statement on the FDA Safety Announcement Regarding Tumor Necrosis Factor (TNF) Blockers
Jun. 18, 2008	Amgen and Wyeth Statement on Outcome of Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) Meeting
Jun. 18, 2008	Enbrel® (etanercept) Application for the Treatment of Pediatric Psoriasis to be Discussed at FDA Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) Meeting
Jun. 16, 2008	Amgen Statement on Briefing Materials Prepared for June 18, 2008 DODAC Meeting
Jun. 4, 2008	Amgen and Wyeth Statement on the FDA Early Communication About Tumor Necrosis Factor (TNF) Blockers
May 1, 2008	Amgen to Participate in Dermatologic and Ophthalmic Drugs Advisory Committee Meeting in June
Mar. 17, 2008	Press Release: Amgen Announces Update to U.S. Prescribing Information for Enbrel®
Mar. 17, 2008	Letter to Healthcare Professionals

Background Documents

Prescribing information for Enbrel®

footer